Roche Acquires Mirus to Advance Research in the Field Of RNAi Delivery.

PR Newswire;  July 22, 2008 ;     700+ words ......will acquire Mirus Bio Corporation...effectively getting RNAi therapeutics to specific...fully enabled RNAi therapeutics. The expertise...be known as Mirus Bio LLC, without...medicines, known as RNAi therapeutics, is on the horizon. RNAi ...

Mirus Bio Announces Delivery Technology Breakthrough for RNAi...

PR Newswire;  July 27, 2007 ;     700+ words ......Researchers at Mirus Bio Corporation have...a foundation for RNAi therapeutics to disable cancer...to hepatocytes . Mirus Bio, which was founded...to development of RNAi therapeutics for diseases affecting...successfully administering RNAi-based medicines ...

Mirus Bio Announces New RNAi Tool to Analyze Gene Function.

PR Newswire;  September 22, 2006 ;     592 words ...MADISON, Wis., Sept. 22 /PRNewswire/ -- Mirus Bio Corporation announced the development...Dr. Peter S. Linsley and the group at Mirus Bio led by Dr. David L. Lewis. The team utilized...mice. The new technique developed at Mirus Bio bypasses these hurdles and enables any...

Mirus Bio Announces Efficient New Genetic Immunization Method to Produce...

PR Newswire;  March 15, 2006 ;     489 words ......March 15 /PRNewswire/ -- Scientists at Mirus Bio Corporation have developed a genetic...hurdles. The new technique developed at Mirus Bio bypasses these hurdles and enables research...portfolio, notes Jon A. Wolff, M.D., Mirus Bio's Chief Scientific Officer. This research...

Learn About The Future of RNAi Therapeutics: Drug Pipelines and Prospects.

Canadian Corporate News;  October 9, 2008 ;     700+ words ......available in its catalogue. The Future of RNAi Therapeutics: Drug Pipelines and Prospects http...reportlinker.com/p096060/The-Future-of-RNAi-Therapeutics-Drug-Pipelines-and-Prospects.html...the coming years. 'The Future of RNAi Therapeutics: Drug pipelines and prospects' is...

Mirus Bio Awarded Broad European Patent Covering Intravascular Injection...

PR Newswire;  October 31, 2006 ;     427 words ...MADISON, Wis., Oct. 31 /PRNewswire/ -- Mirus Bio Corporation announced today the grant...produce the encoded therapeutic agent. Mirus Bio is applying this powerful tool to such...domestically, commented Russell Smestad, Mirus Bio's President. The lack of safe, clinically...

Mirus Bio Corporation Enters Into Agreement With Pfizer Inc. to Evaluate...

PR Newswire;  January 9, 2007 ;     613 words ...MADISON, Wis., Jan. 9 /PRNewswire/ -- Mirus Bio Corporation announced today it has entered...animal models. The studies will utilize Mirus Bio's nucleic acid delivery platforms to...interference, commented Russell Smestad, Mirus Bio's President. We are excited that this...

Mirus Bio Awarded Broad RNAi Patent Using Hydrodynamic Intravascular...

PR Newswire;  December 14, 2006 ;     611 words ...MADISON, Wis., Dec. 14 /PRNewswire/ -- Mirus Bio Corporation announced today the grant...for certain human therapeutic tissues. Mirus Bio is increasingly being recognized for...delivery, commented Russell Smestad, Mirus Bio's President. Hydrodynamic injection has...

RNAi Therapeutics 2008 Market Report Provides an Extensive Analysis of the...

M2 Presswire;  December 17, 2007 ;     700+ words ......December 2007-Research and Markets: RNAi Therapeutics 2008 Market Report Provides an Extensive...Intellectual Property (IP) Landscape in RNAi Therapeutics Space, RNAi Technology Trends, and...c77611) has announced the addition of RNAi Therapeutics 2008 Market Report to their ...

Alnylam Pharmaceuticals Launches InterfeRx(TM) Licensing Program for RNAi...

PR Newswire;  December 11, 2003 ;     580 words ......Pharmaceuticals, Inc., the leading RNAi therapeutics company, today announced the launch...InterfeRx(TM) licensing program for RNAi therapeutics. Through the InterfeRx program, Alnylam...grant licenses for the development of RNAi therapeutics under the company's broad portfolio...

Mirus Bio Enters into Research Agreement with Genzyme.

PR Newswire;  September 8, 2004 ;     461 words ...MADISON, Wis., Sept. 8 /PRNewswire/ -- Mirus Bio Corporation today announced that it has entered into...available for use in internal research programs. About Mirus Bio Corporation: Mirus Bio Corporation is a leader in the emerging fields of...

Mirus Bio Awarded Grants & Contracts of Over $5 Million.

PR Newswire;  August 23, 2007 ;     539 words ...MADISON, Wis., Aug. 23 /PRNewswire/ -- Mirus Bio Corporation today announced that it has...research team, commented Jon Wolff, M.D., Mirus Bio's CSO and co-founder. In this era of...for multiple disease indications. About Mirus Bio Corporation: Mirus Bio Corporation is...

Alnylam Grants Nastech a License to Develop RNAi Therapeutics Against...

PR Newswire;  July 20, 2005 ;     700+ words ......Pharmaceuticals, Inc. , a leading RNAi therapeutics company, announced today that it...discover, develop, and commercialize RNAi therapeutics directed against TNF-alpha, a protein...efforts toward the commercialization of RNAi therapeutics, said John Maraganore, Ph.D., President...

Intradigm's ICS-283: First Demonstration of Clinically Viable,...

PR Newswire;  December 10, 2004 ;     620 words ......viable systemically administered RNAi therapeutics. This major milestone in the development of systemic RNAi therapeutics toward human clinical trials...significantly advanced the field of RNAi therapeutics in this first ever demonstration...

ROCHE TO BUY MIRUS BIO COMPANY TO PAY $125 MILLION FOR CITY...

Wisconsin State Journal (Madison, WI);  July 23, 2008 ;     479 words ......biotechnology companies, is buying a Madison biotech. Mirus Bio Corp. will be purchased by Roche for $125...will become a stand-alone operation called Mirus Bio. Twenty employees will stay with Mirus Bio at its current location, 505 S. Rosa Road...